Skip to main content

Advertisement

SpringerLink
Log in

A Granular Approach to a Patient with Diarrhea and Flushing

  • UNM CLINICAL CASE CONFERENCES
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Gilfillan AM, Austin SJ, Metcalfe DD. MC biology: introduction and overview. Adv Exp Med Biol. 2011;716:2–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Krishnaswamy G, Kelley J, Johnson D, Youngberg G, et al. The human mast cell: functions in physiology and disease. Front Biosci. 2001;6:1109–11027.

    Article  Google Scholar 

  3. Okayama Y, Kawakami T. Development, migration, and survival of mast cells. Immune Res. 2006;34:97–115.

    Article  CAS  Google Scholar 

  4. Migalovich-Sheikhet H, Friedman S, Mankuta D, Levi-Schaffer F. Novel identified receptors on mast cells. Front Immunol. 2012;3:238.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Ashman LK. The biology of stem cell factor and its receptor C-kit. Int J Biochem Cell Biol. 1999;31:1037–1051.

    Article  CAS  PubMed  Google Scholar 

  6. Miettinen M, Lasota J. KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol. 2005;13:205–220.

    Article  CAS  PubMed  Google Scholar 

  7. Lundequist A, Pejler G. Biological implications of preformed mast cell mediators. Cell Mol Life Sci. 2011;6:965–975.

    Article  CAS  Google Scholar 

  8. Payne V, Kam PC. Mast cell tryptase: a review of its physiology and clinical significance. Anaesthesia. 2004;59:695–703.

    Article  CAS  PubMed  Google Scholar 

  9. Lawrence JB, Friedman BS, Travis WD, Chinchilli VM. Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis. Am J Med. 1991;91:612–624.

    Article  CAS  PubMed  Google Scholar 

  10. Arock M. Mastocytosis, classification, biological diagnosis and therapy. Ann Biol Clin. 2004;62:657–669.

    CAS  Google Scholar 

  11. Ertugrul A, Bostanci I, Ozturk Kaymak A, Gurkan A. Pediatric cutaneous mastocytosis and c-KIT mutation screening. Allergy Asthma Proc. 2019;40:123–128.

    Article  PubMed  Google Scholar 

  12. Lim KH, Tefferi A, Lasho TL, Finke C, et al. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood. 2009;113:5727–5736.

    Article  CAS  PubMed  Google Scholar 

  13. Parsons ME, Ganellin CR. Histamine and its receptors. Br J Pharmacol. 2006;147:127–135.

    Article  CAS  Google Scholar 

  14. Togias A. H1-receptors: localization and role in airway physiology and in immune functions. J Allergy Clin Immunol. 2003;112:60–68.

    Article  Google Scholar 

  15. Haas HL, Sergeeva OA, Selbach O. Histamine in the nervous system. Physiol Rev. 2008;88:1183–1241.

    Article  CAS  PubMed  Google Scholar 

  16. Thrumond R. The histamine H4 receptor: from orphan to the clinic. Front Pharmacol. 2015;6:65.

    Google Scholar 

  17. He A, Shi GP. Mast cell chymase and tryptase as targets for cardiovascular and metabolic diseases. Curr Pharm Des. 2013;19:1114–1125.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Martins C, Teixeira C, Ribeiro S, Trabulo D, et al. Systemic mastocytosis: a rare cause of non-cirrhotic portal hypertension. World J Gastroenterol. 2016;22:6559–6564.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Schwartz LB. Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders. Leuk Res. 2001;25:553–562.

    Article  CAS  PubMed  Google Scholar 

  20. Metcalfe DD. Classification and diagnosis of mastocytosis: current status. J Invest Dermatol. 1991;96:60–65.

    Article  Google Scholar 

  21. Skrabs CC. Darier sign, a historical note. Arch Dermatol. 2002;138:1253–1254.

    Article  PubMed  Google Scholar 

  22. Ray D, Williams G. Pathophysiological causes and clinical significance of flushing. Br J Hosp Med. 1993;50:594–598.

    CAS  PubMed  Google Scholar 

  23. Butterfield JH. Systemic mastocytosis: clinical manifestations and differential diagnosis. Immunol Allergy Clin N Am. 2006;26:487–513.

    Article  Google Scholar 

  24. Jensen RT. Gastrointestinal abnormalities and involvement in systemic mastocytosis. Hematol Oncol Clin N Am. 2000;14:579–623.

    Article  CAS  Google Scholar 

  25. Cherner JA, Jensen RT, Dubois A, O’Dorisio TM, et al. Gastrointestinal dysfunction in systemic mastocytosis. A prospective study. Gastroenterology. 1988;95:657–667.

    Article  CAS  PubMed  Google Scholar 

  26. Doyle LA, Sepehr GJ, Hamilton MJ, Akin C, et al. A clinico-pathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients. Am J Surg Pathol. 2014;38:832–843.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Arguedas MR, Ferrante D. Systemic mastocytosis and giant gastroduodenal ulcer. Gastrointest Endosc. 2001;54:530–533.

    Article  CAS  PubMed  Google Scholar 

  28. Scolapio JS, Wolfe J III, Malavet P, Woodward TA. Endoscopic findings in systemic mastocytosis. Gastrointest Endosc. 1996;44:608–610.

    Article  CAS  PubMed  Google Scholar 

  29. Horny HP, Kaiserling E, Campbell M, Parwaresch MR, et al. Liver findings in generalized mastocytosis. A clinicopathologic study. Cancer. 1989;63:532–538.

    Article  CAS  PubMed  Google Scholar 

  30. Capron JP, Lebrec D, Degott C, Chivrac D, et al. Portal hypertension in systemic mastocytosis. Gastroenterology. 1978;74:595–597.

    Article  CAS  PubMed  Google Scholar 

  31. Horny HP, Metcalfe DD, Bennett JM, Bain BJ, et al. Mastocytosis (mast cell disease). World Health Organization (WHO) classification of tumors. Pathology Genetics. Tumors of haematopoietic and lymphoid tissues. Lyon, France: International agency for research on cancer; 2008:54–63.

  32. Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy. 2008;63:226–232.

    Article  CAS  PubMed  Google Scholar 

  33. Horan RF, Sheffer AL, Austen KF. Cromolyn sodium in the management of systemic mastocytosis. J Allergy Clin Immunol. 1990;85:852–855.

    Article  CAS  PubMed  Google Scholar 

  34. Tolar J, Tope WD, Neglia JP. Leukotriene-receptor inhibition for the treatment of systemic mastocytosis. N Engl J Med. 2004;350:735–736.

    Article  CAS  PubMed  Google Scholar 

  35. Kasamon YL, Kp CW, Subramania S, Ma L. FDA approval summary: midostaurin for the treatment of advanced systemic mastocytosis. Oncologist. 2018;23:1511–1519.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Vega-Ruiz A, Cortes JE, Sever M, Manshouri T. Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis. Leuk Res. 2009;33:1481–1484.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Ustun C, Gotlib J, Popat U, Artz A, et al. Consensus opinion on allogeneic hematopoietic cell transplantation in advanced systemic mastocytosis. Biol Blood Marrow Transpl. 2016;22:1348–1356.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, MSC 10-5550, 1 University of New Mexico, Albuquerque, NM, USA

    Anas Gremida & Denis McCarthy

  2. Division of Gastroenterology and Hepatology, Presbyterian Hospital, Albuquerque, NM, USA

    Fazia Mir

Authors
  1. Anas Gremida
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fazia Mir
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Denis McCarthy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anas Gremida.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gremida, A., Mir, F. & McCarthy, D. A Granular Approach to a Patient with Diarrhea and Flushing. Dig Dis Sci 64, 1792–1797 (2019). https://doi.org/10.1007/s10620-019-05673-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-019-05673-9

Keywords

Search

Navigation